TOKYO--(BUSINESS WIRE)--Nov 1, 2023--NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) commercialized “NK-304LCO” stainless steel for injection needles in November 2020, which is compliant with the Cobalt composition regulation of the European Medical Devices ...
LONDON & NEW YORK--(BUSINESS WIRE)--Nov 1, 2023--ViroCell Biologics (“ViroCell” or the “Company”), a specialist contract development and manufacturing organisation (“CDMO”) for cell and gene therapy (CGT) clinical trials, announces that the Company is now able to ...
<p style="TEXT-ALIGN:CENTER">- Data demonstrate feasibility, tolerability, and early efficacy of mRNA/LNP in vivo CAR-M therapy in pre-clinical models of metastatic solid tumors<p style="TEXT-ALIGN:CENTER">- Proof of concept achieved for platform under the Moderna ...